Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter

Imported from official source

Recall

Safety Classified by Officially

November 06,2026 – East Windsor, New Jersey, Eugia US LLC (f/k/a Auro Medics Pharma LLC) is voluntarily recalling lot number 3VM26026A of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) to the hospital/healthcare facility/user level due to the presence of particulate matter identified as a glass particle inside the vial.

Risk Statement: There is a reasonable probability that use of product containing glass particulates can cause serious adverse health consequences such as blockage and clotting in blood vessels, which can cut off blood flow to vital organs, lead to a life-threatening blood clot in the lungs (pulmonary embolism) and cause permanent organ damage or death. Additionally, these particles may cause local vein irritation, inflammatory reaction, aggravation of preexisting infections, and allergic reactions. Greater susceptibility may exist in neonates, infants and patients with compromised organ function. To date, Eugia US LLC has not received any reports of adverse events related to this recall.

Vancomycin hydrochloride for injection is a glycopeptide antibacterial indicated in adult and pediatric patients (Neonates and Older) for the treatment of Septicaemia, Infective Endocarditis, Skin and Skin Structure Infections, Bone Infections and Lower Respiratory Tract Infections.

The recalled product is packaged in 30 mL vial and packed as 10 (vials) X 10 (Printed cartons) X 01 (Shipper) with NDC code as 55150-471-01.

The product can be identified by product name on carton (NDC 55150-471-10) and vial (NDC 55150-471-01) label and with lot number 3VM26026A and Exp. JUL 2028

Eugia US LLC shipped the entire lot to wholesalers nationwide from September 2, 2026, through September 15, 2026.

This is an extract. The publication continues at the source.

Read the original at the source: http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-fka-auro-medics-pharma-llc-issues-voluntary-nationwide-recall-vancomycin-hydrochloride

Officially imported this from Food and Drug Administration’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Food and Drug Administration — imported from official source
Official source
https://www.fda.gov/about-fda/contact-fda/stay-informed/rss-feeds/recalls/rss.xml RSS
Imported
November 09, 2026 22:03
Versions
1 recorded
Identity
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eugia-us-llc-fka-aur...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.